ACAD
38.17
+0.26
+0.69%
AEMD
7.05
-0.1
-1.40%
APRI
1.35
+0.12
+9.76%
ARNA
2.71
+0.06
+2.26%
ATEC
0.54
-0.03
-5.26%
CNAT
4.05
+0.37
+10.05%
CRXM
0.37
-0.02
-5.13%
CYTX
0.315
+0.016
+5.246%
DXCM
94.19
+0.45
+0.48%
GNMK
10.02
+0.59
+6.26%
HALO
18.41
+0.37
+2.05%
ILMN
201.7
-0.24
-0.12%
INNV
0.148
+0.003
+2.069%
INO
7.73
+0.75
+10.74%
ISCO
3.98
+0.33
+9.04%
ISIS
51.54
-0.02
-0.04%
LGND
95.04
+0.79
+0.84%
LPTN
0.225
+0.015
+7.092%
MBVX
1.685
-0.005
-0.296%
MEIP
1.73
+0.04
+2.37%
MNOV
2.94
-0.03
-1.01%
MRTX
26.66
+1.17
+4.59%
MSTX
0.47
+0.02
+3.96%
NBIX
46.67
+0.41
+0.89%
NUVA
53.75
+1
+1.90%
ONCS
5.2
+0.02
+0.48%
ONVO
2.54
+0.04
+1.60%
OREX
2.89
+0.13
+4.71%
OTIC
23.5
+0.12
+0.51%
QDEL
20.45
-0.25
-1.21%
RCPT
231.96
0.00
0.00%
RGLS
8.27
+0.79
+10.56%
RMD
52.47
+0.82
+1.59%
SCIE
0.015
+0.001
+3.5714%
SPHS
0.89
+0.03
+3.49%
SRNE
13.65
+0.33
+2.48%
TROV
6.33
+0.55
+9.52%
VICL
0.59
+0.03
+5.32%
VOLC
18
0.00
0.00%
ZGNX
18.41
+1.35
+7.91%
ACAD
38.17
+0.26
+0.69%
AEMD
7.05
-0.1
-1.40%
APRI
1.35
+0.12
+9.76%
ARNA
2.71
+0.06
+2.26%
ATEC
0.54
-0.03
-5.26%
CNAT
4.05
+0.37
+10.05%
CRXM
0.37
-0.02
-5.13%
CYTX
0.315
+0.016
+5.246%
DXCM
94.19
+0.45
+0.48%
GNMK
10.02
+0.59
+6.26%
HALO
18.41
+0.37
+2.05%
ILMN
201.7
-0.24
-0.12%
INNV
0.148
+0.003
+2.069%
INO
7.73
+0.75
+10.74%
ISCO
3.98
+0.33
+9.04%
ISIS
51.54
-0.02
-0.04%
LGND
95.04
+0.79
+0.84%
LPTN
0.225
+0.015
+7.092%
MBVX
1.685
-0.005
-0.296%
MEIP
1.73
+0.04
+2.37%
MNOV
2.94
-0.03
-1.01%
MRTX
26.66
+1.17
+4.59%
MSTX
0.47
+0.02
+3.96%
NBIX
46.67
+0.41
+0.89%
NUVA
53.75
+1
+1.90%
ONCS
5.2
+0.02
+0.48%
ONVO
2.54
+0.04
+1.60%
OREX
2.89
+0.13
+4.71%
OTIC
23.5
+0.12
+0.51%
QDEL
20.45
-0.25
-1.21%
RCPT
231.96
0.00
0.00%
RGLS
8.27
+0.79
+10.56%
RMD
52.47
+0.82
+1.59%
SCIE
0.015
+0.001
+3.5714%
SPHS
0.89
+0.03
+3.49%
SRNE
13.65
+0.33
+2.48%
TROV
6.33
+0.55
+9.52%
VICL
0.59
+0.03
+5.32%
VOLC
18
0.00
0.00%
ZGNX
18.41
+1.35
+7.91%
Home » Archive by Category

Xconomy

Under New Initiative, Biocom Scouts for Strategic Partners in Japan

March 3, 2015 – 12:40 pm

After working for years to make inroads in China, San Diego’s Biocom industry group has refocused its global partnering efforts on a new initiative intended to connect emerging life sciences…

[[Click headline to continue reading.]]

Under New Initiative, Biocom Scouts for Strategic Partners in Japan

March 3, 2015 – 12:40 pm

After working for years to make inroads in China, San Diego’s Biocom industry group has refocused its global partnering efforts on a new initiative intended to connect emerging life sciences…

[[Click headline to continue reading.]]

Tiger Teams, Dropping Subs, and Biotech’s Elusive Second Strikes

March 3, 2015 – 4:30 am

Onesie-twosie? Double dipping? The old razzle dazzle? Whatever you call it, it’s a rare feat to sell a biotech company, hold something back to start a new company, then ride that second horse…

[[Click headline to continue reading.]]

Tiger Teams, Dropping Subs, and Biotech’s Elusive Second Strikes

March 3, 2015 – 4:30 am

Onesie-twosie? Double dipping? The old razzle dazzle? Whatever you call it, it’s a rare feat to sell a biotech company, hold something back to start a new company, then ride that second horse…

[[Click headline to continue reading.]]

Finistere Raises $150M for New Fund Focused on Agricultural Biotech

March 2, 2015 – 11:01 am

Finistere Ventures, a San Diego investment firm focused on agricultural biotechnology, said it has closed on $150 million for its second fund. In a regulatory filing, the firm indicates plans to…

[[Click headline to continue reading.]]

Cancer Immunotherapy Companies: Looking Forward and Looking Back

March 2, 2015 – 1:00 am

I’ve been researching one of our local immunotherapy developers here in Seattle, trying to round up the views of industry experts regarding the future prospects of a drug at the front of its…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Flexus, NGM, Illumina, Bob Klein & More

February 26, 2015 – 12:25 pm

A few West Coast companies made news back east this week at the Advances in Genome Biology and Technology conference in Florida, while others (Flexus Biosciences, NGM Biotherapeutics) stayed home to…

[[Click headline to continue reading.]]

Shire Acquires Meritage Pharma in Deal Potentially Worth $245M

February 24, 2015 – 10:01 am

[Updated 2/24/15 6:10 pm. See below.] After acquiring ViroPharma last year in a $4.2 billion deal focused on Cinryze, the Irish pharmaceutical giant Shire says it is following through on a…

[[Click headline to continue reading.]]

Cebix Shuts Down Following Mid-Stage Trial of C-Peptide Drug

February 23, 2015 – 5:40 am

San Diego-based Cebix, which raised about $50 million to advance a C-peptide replacement therapy for treating diabetes-related microvascular problems, has quietly folded its tent. Jacob Fuchs, an…

[[Click headline to continue reading.]]

Innovation Hub: Meet the Science Evangelist

February 20, 2015 – 12:58 pm

Ainissa Ramirez says she’s a “Science Evangelist,” and she travels the country to preach her gospel in classrooms. As a result, the former Yale professor hopes to invigorate…

[[Click headline to continue reading.]]